Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September 2024 as against net loss of Rs 17.16 crore during the previous quarter ended September 2023. Sales declined 18.41% to Rs 346.95 crore in the quarter ended September 2024 as against Rs 425.24 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 346.95 | 425.24 | -18 |
| OPM % | 17.67 | 8.85 | - |
| PBDT | 33.35 | 14.37 | 132 |
| PBT | 8.01 | -11.84 | LP |
| NP | 8.01 | -17.16 | LP |